Dopamine D3 receptor is necessary for ethanol consumption: An approach with buspirone

Neuropsychopharmacology

Volumn 39, Issue 8, 2014, Pages 2017-2028

  Leggio, Gian Marco ^a   Camillieri, Giovanni ^a   Platania, Chiara B M ^a   Castorina, Alessandro ^a   Marrazzo, Giuseppina ^a   Torrisi, Sebastiano Alfio ^a   Nona, Christina N ^b   D'Agata, Velia ^a   Nobrega, José ^b   Stark, Holger ^c   Bucolo, Claudio ^a   Le Foll, Bernard ^b   Drago, Filippo ^a   Salomone, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; ALCOHOL; ANA 12; BRAIN DERIVED NEUROTROPHIC FACTOR; BUSPIRONE; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; RECEPTOR BLOCKING AGENT; RECEPTOR FOR ACTIVATED C KINASE 1; U 99194 A; UNCLASSIFIED DRUG; GNB2-RS1 PROTEIN, MOUSE; NEUROPEPTIDE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; GENE DELETION; GENE OVEREXPRESSION; LIMBIC CORTEX; MALE; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; REWARD; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DECISION MAKING; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ALCOHOL DRINKING; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUSPIRONE; CHOICE BEHAVIOR; CORPUS STRIATUM; DRUG-SEEKING BEHAVIOR; ETHANOL; MALE; MICE; MICE, KNOCKOUT; NEUROPEPTIDES; RECEPTORS, DOPAMINE D3;

EID: 84902547945     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.51     Document Type: Article

References (74)

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH et al (1996). A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93: 1945-1949.
2. Beaulieu JM, Gainetdinov RR, Caron MG (2007). The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28: 166-172.
3. Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR et al (2013). Modification of cocaine self-administration by buspirone (buspar(R)): potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol 16: 445-458.
4. Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J et al (2012). Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci 32: 1353-1359.
5. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991). Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564: 203-219.
6. Bowers MS, Chen BT, Bonci A (2010). AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron 67: 11-24.
7. Boyce-Rustay JM, Risinger FO (2003). Dopamine D3 receptor knockout mice and the motivational effects of ethanol. Pharmacol Biochem Behav 75: 373-379.
8. Brand I, Fliegel S, Spanagel R, Noori HR (2013). Global ethanolinduced enhancements of monoaminergic neurotransmission: a meta-analysis study. Alcohol Clin Exp Res 37: 2048-2057.
9. Carr KD, Yamamoto N, Omura M, Cabeza de Vaca S, Krahne L (2002). Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and foodrestricted rats. Psychopharmacology (Berl) 163: 76-84.
10. Cazorla M, Premont J, Mann A, Girard N, Kellendonk C, Rognan D (2011). Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 121: 1846-1857.
11. Cohen C, Perrault G, Sanger DJ (1998). Preferential involvement of D3 versus D2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats. Psychopharmacology (Berl) 140: 478-485.
12. Collo G, Bono F, Cavalleri L, Plebani L, Merlo Pich E, Millan MJ et al (2012). Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways. J Neurochem 120: 765-778.
13. Collo G, Bono F, Cavalleri L, Plebani L, Mitola S, Merlo Pich E et al (2013). Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling. Mol Pharmacol 83: 1176-1189.
14. Crabbe JC, Kosobud A, Young ER, Janowsky JS (1983). Polygenic and single-gene determination of responses to ethanol in BXD/ Ty recombinant inbred mouse strains. Neurobehav Toxicol Teratol 5: 181-187.
15. Crabbe JC, Spence SE, Brown LL, Metten P (2011). Alcohol preference drinking in a mouse line selectively bred for high drinking in the dark. Alcohol 45: 427-440.
16. Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC et al (2000). Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20: 8677-8684.
17. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G (1985). Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348: 201-203.
18. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P (2001). BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411: 86-89.
19. Harrison SJ, Nobrega JN (2009). A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice. Psychopharmacology (Berl) 207: 47-56.
20. He DY, Neasta J, Ron D (2010). Epigenetic regulation of BDNF expression via the scaffolding protein RACK1. J Biol Chem 285: 19043-19050.
21. Heidbreder CA, Andreoli M, Marcon C, Hutcheson DM, Gardner EL, Ashby CR Jr. (2007). Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict Biol 12: 35-50.
22. Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ et al (2005). The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49: 77-105.
23. Heidbreder CA, Newman AH (2010). Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann N Y Acad Sci 1187: 4-34.
24. Higley AE, Kiefer SW, Li X, Gaal J, Xi ZX, Gardner EL (2011). Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamineinduced reinstatement of drug-seeking in rats. Eur J Pharmacol 659: 187-192.
25. Ikemoto S, Bonci A (2013). Neurocircuitry of drug reward. Neuropharmacology 76: 329-341.
26. Imperato A, Di Chiara G (1986). Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239: 219-228.
27. Jeanblanc J, He DY, McGough NN, Logrip ML, Phamluong K, Janak PH et al (2006). The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption. J Neurosci 26: 1457-1464.
28. Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov RR et al (2002). Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112: 39-49.
29. Joyce JN, Millan MJ (2005). Dopamine D3 receptor antagonists as therapeutic agents. Drug Discov Today 10: 917-925.
30. Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME et al (1998). Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 18: 2231-2238.
31. Koob GF (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177-184.
32. Kula NS, Baldessarini RJ, Kebabian JW, Neumeyer JL (1994). S-(+)-aporphines are not selective for human D3 dopamine receptors. Cell Mol Neurobiol 14: 185-191.
33. Le Foll B, Boileau I (2013). Repurposing buspirone for drug addiction treatment. Int J Neuropsychopharmacol 16: 251-253.
34. Le Foll B, Diaz J, Sokoloff P (2003). Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 47: 176-183.
35. Le Foll B, Diaz J, Sokoloff P (2005a). Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci 76: 1281-1296.
36. Le Foll B, Diaz J, Sokoloff P (2005b). A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 16: 175-178.
37. Le Foll B, Frances H, Diaz J, Schwartz JC, Sokoloff P (2002). Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 15: 2016-2026.
38. Levant B (1997). The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49: 231-252.
39. Li YC, Xi D, Roman J, Huang YQ, Gao WJ (2009). Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex. J Neurosci 29: 15551-15563.
40. Mannoury la Cour C, Salles MJ, Pasteau V, Millan MJ (2011). Signaling pathways leading to phosphorylation of Akt and GSK- 3beta by activation of cloned human and rat cerebral D(2)and D(3) receptors. Mol Pharmacol 79: 91-105.
41. Martin KF, Phillips I, Hearson M, Prow MR, Heal DJ (1992). Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br J Pharmacol 107: 15-21.
42. Mash DC (1997). D3 receptor binding in human brain during cocaine overdose. Mol Psychiatry 2: 5-6.
43. McGough NN, He DY, Logrip ML, Jeanblanc J, Phamluong K, Luong K et al (2004). RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci 24: 10542-10552.
44. McQuade JA, Xu M, Woods SC, Seeley RJ, Benoit SC (2003). Ethanol consumption in mice with a targeted disruption of the dopamine-3 receptor gene. Addict Biol 8: 295-303.
45. Mereu G, Fadda F, Gessa GL (1984). Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res 292: 63-69.
46. Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994). Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91: 11271-11275.
47. Neisewander JL, Fuchs RA, Tran-Nguyen LT, Weber SM, Coffey GP, Joyce JN (2004). Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 29: 1479-1487.
48. Nelson RJ, Young KA (1998). Behavior in mice with targeted disruption of single genes. Neurosci Biobehav Rev 22: 453-462.
49. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P (2012). Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol 84: 882-890.
50. Nuutinen S, Kiianmaa K, Panula P (2011). DARPP-32 and Akt regulation in ethanol-preferring AA and ethanol-avoiding ANA rats. Neurosci Lett 503: 31-36.
51. Pierce RC, Kumaresan V (2006). The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30: 215-238.
52. Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY et al (2000). Pharmacological actions of a novel, highaffinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294: 1154-1165.
53. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005). Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 84: 53-63.
54. Rhodes JS, Ford MM, Yu CH, Brown LL, Finn DA, Garland T Jr. et al (2007). Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav 6: 1-18.
55. Rice OV, Patrick J, Schonhar CD, Ning H, Ashby CR Jr. (2012). The effects of the preferential dopamine D(3) receptor antagonist S33138 on ethanol binge drinking in C57BL/6J mice. Synapse 66: 975-978.
56. Robbins TW, Everitt BJ (1996). Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6: 228-236.
57. Segal DM, Moraes CT, Mash DC (1997). Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 45: 335-339.
58. Silvestre JS, O'Neill MF, Fernandez AG, Palacios JM (1996). Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat. Eur J Pharmacol 318: 257-265.
59. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146-151.
60. Song R, Yang RF, Wu N, Su RB, Li J, Peng XQ et al (2012). YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptorknockout mice. Addict Biol 17: 259-273.
61. Soppet D, Escandon E, Maragos J, Middlemas DS, Reid SW, Blair J et al (1991). The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65: 895-903.
62. Staley JK, Mash DC (1996). Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16: 6100-6106.
63. Svenningsson P, Nairn AC, Greengard P (2005). DARPP-32 mediates the actions of multiple drugs of abuse. Aaps J 7: E353-E360.
64. Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K et al (1997). I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. J Pharmacol Exp Ther 282: 1011-1019.
65. Thanos PK, Katana JM, Ashby CR Jr., Michaelides M, Gardner EL, Heidbreder CA et al (2005). The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol Biochem Behav 81: 190-197.
66. Vassoler FM, White SL, Schmidt HD, Sadri-Vakili G, Pierce RC (2013). Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci 16: 42-47.
67. Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke- Haerter P, Drescher K, Gross G et al (2006). The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. Faseb J 20: 2223-2233.
68. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(Suppl 1): 3-8.
69. Weiss F, Hurd YL, Ungerstedt U, Markou A, Plotsky PM, Koob GF (1992). Neurochemical correlates of cocaine and ethanol selfadministration. Ann N Y Acad Sci 654: 220-241.
70. Wise RA (1973). Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 29: 203-210.
71. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492.
72. Wong H, Dockens RC, Pajor L, Yeola S, Grace JE Jr., Stark AD et al (2007). 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats. Drug Metab Dispos 35: 1387-1392.
73. Xing B, Guo J, Meng X, Wei SG, Li SB (2012). The dopamine D1 but not D3 receptor plays a fundamental role in spatial working memory and BDNF expression in prefrontal cortex of mice. Behav Brain Res 235: 36-41.
74. Yoshimoto K, McBride WJ, Lumeng L, Li TK (1992). Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 9: 17-22.